Skip to search formSkip to main contentSkip to account menu

agonists

Used with chemicals, drugs, and endogenous substances to indicate substances or agents that have affinity for a receptor and intrinsic activity at… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2014
Review
2014
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of injective anti-diabetic drugs that improve glycemic control and… 
Highly Cited
2012
Highly Cited
2012
Glucagon-like peptide-1 receptor agonists (GLP-1 RA) are effective for obese patients with type 2 diabetes mellitus (T2DM… 
Highly Cited
2012
Highly Cited
2012
Glucagon-Like Peptide-1 receptor agonists (GLP-1RAs), approved as glucose-lowering drugs for the treatment of type 2 diabetes… 
Review
2012
Review
2012
Glucagon-like peptide-1 receptor (GLP-1R) agonists have been shown to regulate blood glucose concentrations by mechanisms… 
Highly Cited
2011
Highly Cited
2011
Background Pathogenic versus protective outcomes to Dengue virus (DENV) infection are associated with innate immune function… 
Highly Cited
2008
Highly Cited
2008
Background Adenosine levels rise during inflammation and modulate inflammatory responses by engaging with four different G… 
Review
2008
Review
2008
GPR119 is a G protein‐coupled receptor expressed predominantly in the pancreas (β‐cells) and gastrointestinal tract… 
Highly Cited
2007
Highly Cited
2007
Fingolimod (FTY720) is the first of a novel class: sphingosine 1-phosphate (S1P) receptor modulator and is currently in phase 3… 
Highly Cited
1997
Review
1993
Review
1993
Potentiation of glucose-induced insulin secretion by intestinal factors has been described for many years. Today, two major…